1
|
Hooi JKY, Lai WY, Ng WK, Suen MMY,
Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu
JCY, et al: Global prevalence of helicobacter pylori
infection: Systematic review and meta-analysis. Gastroenterology.
153:420–429. 2017.PubMed/NCBI View Article : Google Scholar
|
2
|
Wang C, Yuan Y and Hunt RH: The
association between Helicobacter pylori infection and early
gastric cancer: A meta-analysis. Am J Gastroenterol. 102:1789–1798.
2007.PubMed/NCBI View Article : Google Scholar
|
3
|
IARC Helicobacter pylori Working
Group: Helicobacter pylori eradication as a strategy for
preventing gastric cancer. IARC Working Group Reports, No. 8. IARC,
Lyon, 2014.
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011.PubMed/NCBI View Article : Google Scholar
|
5
|
Yakirevich E and Resnick MB: Pathology of
gastric cancer and its precursor lesions. Gastroenterol Clin North
Am. 42:261–284. 2013.PubMed/NCBI View Article : Google Scholar
|
6
|
Salama NR, Hartung ML and Muller A: Life
in the human stomach: Persistence strategies of the bacterial
pathogen Helicobacter pylori. Nat Rev Microbiol. 11:385–399.
2013.PubMed/NCBI View Article : Google Scholar
|
7
|
Cover TL and Blaser MJ: Helicobacter
pylori in health and disease. Gastroenterology. 136:1863–1873.
2009.PubMed/NCBI View Article : Google Scholar
|
8
|
Kinlen LJ, Webster AD, Bird AG, Haile R,
Peto J, Soothill JF and Thompson RA: Prospective study of cancer in
patients with hypogammaglobulinaemia. Lancet. 1:263–266.
1985.PubMed/NCBI View Article : Google Scholar
|
9
|
Salzer U, Maul-Pavicic A,
Cunningham-Rundles C, Urschel S, Belohradsky BH, Litzman J, Holm A,
Franco JL, Plebani A, Hammarstrom L, et al: ICOS deficiency in
patients with common variable immunodeficiency. Clin Immunol.
113:234–240. 2004.PubMed/NCBI View Article : Google Scholar
|
10
|
Hutloff A, Dittrich AM, Beier KC,
Eljaschewitsch B, Kraft R, Anagnostopoulos I and Kroczek RA: ICOS
is an inducible T-cell co-stimulator structurally and functionally
related to CD28. Nature. 397:263–266. 1999.PubMed/NCBI View
Article : Google Scholar
|
11
|
Burugu S, Dancsok AR and Nielsen TO:
Emerging targets in cancer immunotherapy. Semin Cancer Biol.
52:39–52. 2018.PubMed/NCBI View Article : Google Scholar
|
12
|
Wikenheiser DJ and Stumhofer JS: ICOS
Co-stimulation: Friend or foe? Front Immunol. 7(304)2016.PubMed/NCBI View Article : Google Scholar
|
13
|
Wang Y, Wang H, Yao H, Li C, Fang JY and
Xu J: Regulation of PD-L1: Emerging routes for targeting tumor
immune evasion. Front Pharmacol. 9(536)2018.PubMed/NCBI View Article : Google Scholar
|
14
|
Marzec M, Zhang Q, Goradia A, Raghunath
PN, Liu X, Paessler M, Wang HY, Wysocka M, Cheng M, Ruggeri BA and
Wasik MA: Oncogenic kinase NPM/ALK induces through STAT3 expression
of immunosuppressive protein CD274 (PD-L1, B7-H1). Proc Natl Acad
Sci USA. 105:20852–20857. 2008.PubMed/NCBI View Article : Google Scholar
|
15
|
Noman MZ, Desantis G, Janji B, Hasmim M,
Karray S, Dessen P, Bronte V and Chouaib S: PD-L1 is a novel direct
target of HIF-1α, and its blockade under hypoxia enhanced
MDSC-mediated T cell activation. J Exp Med. 211:781–790.
2014.PubMed/NCBI View Article : Google Scholar
|
16
|
Feng J, Yang H, Zhang Y, Wei H, Zhu Z, Zhu
B, Yang M, Cao W, Wang L and Wu Z: Tumor cell-derived lactate
induces TAZ-dependent upregulation of PD-L1 through GPR81 in human
lung cancer cells. Oncogene. 36:5829–5839. 2017.PubMed/NCBI View Article : Google Scholar
|
17
|
Chang WL, Yeh YC and Sheu BS: The impacts
of H. pylori virulence factors on the development of
gastroduodenal diseases. J Biomed Sci. 25(68)2018.PubMed/NCBI View Article : Google Scholar
|
18
|
Matos JI, de Sousa HA, Marcos-Pinto R and
Dinis-Ribeiro M: Helicobacter pylori CagA and VacA genotypes
and gastric phenotype: A meta-analysis. Eur J Gastroenterol
Hepatol. 25:1431–1441. 2013.PubMed/NCBI View Article : Google Scholar
|
19
|
Lina TT, Pinchuk IV, House J, Yamaoka Y,
Graham DY, Beswick EJ and Reyes VE: CagA-dependent downregulation
of B7-H2 expression on gastric mucosa and inhibition of Th17
responses during Helicobacter pylori infection. J Immunol.
191:3838–3846. 2013.PubMed/NCBI View Article : Google Scholar
|
20
|
Vacanti NM, Cheng H, Hill PS, Guerreiro
JD, Dang TT, Ma M, Watson S, Hwang NS, Langer R and Anderson DG:
Localized delivery of dexamethasone from electrospum fibers reduces
the foreign body response. Biomacromolecules. 13:3031–3038.
2012.PubMed/NCBI View Article : Google Scholar
|
21
|
de Figueiredo Soares T, de Magalhães
Queiroz DM, Mendes EN, Rocha GA, Rocha Oliveira AM, Alvares Cabral
MM and de Oliveira CA: The interrelationship between
helicobacter pylori vacuolating cytotoxin and gastric
carcinoma. Am J Gastroenterol. 93:1841–1847. 1998.PubMed/NCBI View Article : Google Scholar
|
22
|
Sugimoto M, Zali MR and Yamaoka Y: The
association of vacA genotypes and Helicobacter
pylori-related gastroduodenal diseases in the middle east. Eur
J Clin Microbiol Infect Dis. 28:1227–1236. 2009.PubMed/NCBI View Article : Google Scholar
|
23
|
Cover TL and Blanke SR: Helicobacter
pylori VacA, a paradigm for toxin multifunctionality. Nat Rev
Microbiol. 3:320–332. 2005.PubMed/NCBI View Article : Google Scholar
|
24
|
Galmiche A, Rassow J, Doye A, Cagnol S,
Chambard JC, Contamin S, de Thillot V, Just I, Ricci V, Solcia E,
et al: The N-terminal 34 kDa fragment of Helicobacter pylori
vacuolating cytotoxin targets mitochondria and induces cytochrome c
release. EMBO J. 19:6361–6370. 2000.PubMed/NCBI View Article : Google Scholar
|
25
|
Abdi E, Latifi-Navid S, Latifi-Navid H and
Safarnejad B: Helicobacter pylori vacuolating cytotoxin
genotypes and preneoplastic lesions or gastric cancer risk: A
meta-analysis. J Gastroenterol Hepatol. 31:734–744. 2016.PubMed/NCBI View Article : Google Scholar
|
26
|
Sipponen P and Price AB: The sydney system
for classification of gastritis 20 years ago. J Gastroenterol
Hepatol. 1 (Suppl 26):31–34. 2011.PubMed/NCBI View Article : Google Scholar
|
27
|
Luna LG: Manual of histologic staining
methods of the Armed Forces Institute of Pathology. Blakiston
Division, McGraw-Hill, New York, NY, 1968.
|
28
|
Sambrook J and Green MR: Molecular
cloning: A laboratory manuals. Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY, 2012.
|
29
|
Rudi J, Kolb C, Maiwald M, Kuck D, Sieg A,
Galle PR and Stremmel W: Diversity of Helicobacter pylori
vacA and cagA genes and relationship to VacA and CagA protein
expression, cytotoxin production, and associated diseases. J Clin
Microbiol. 36:944–948. 1998.PubMed/NCBI
|
30
|
Wagih HM, El-Ageery SM and Alghaithy AA: A
study of RUNX3, E-cadherin and β-catenin in CagA-positive
Helicobacter pylori associated chronic gastritis in Saudi
patients. Eur Rev Med Pharmacol Sci. 19:1416–1429. 2015.PubMed/NCBI
|
31
|
Osman EY, El-Eragi AM, Musa AM, El-Magboul
SB, A/Rahman MB and Abdo AE: Detection of Helicobacter
pylori glmM gene in bovine milk using Nested polymerase chain
reaction. Vet World. 8:913–917. 2015.PubMed/NCBI View Article : Google Scholar
|
32
|
Rhead JL, Letley DP, Mohammadi M, Hussein
N, Mohagheghi MA, Eshagh Hosseini M and Atherton JC: A new
Helicobacter pylori vacuolating cytotoxin determinant, the
intermediate region, is associated with gastric cancer.
Gastroenterology. 133:926–936. 2007.PubMed/NCBI View Article : Google Scholar
|
33
|
Chomczynski P and Sacchi N: Single-step
method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal Biochem.
162:156–159. 1987.PubMed/NCBI View Article : Google Scholar
|
34
|
Yilmaz V, Oflazer P, Aysal F, Durmus H,
Poulas K, Yentur SP, Gulsen-Parman Y, Tzartos S, Marx A, Tuzun E,
et al: Differential Cytokine Changes in Patients with Myasthenia
Gravis with Antibodies against AChR and MuSK. PLoS One.
10(e0123546)2015.PubMed/NCBI View Article : Google Scholar
|
35
|
Moraes-Vieira PM, Takenaka MC, Silva HM,
Monteiro SM, Agena F, Lemos F, Saitovitch D, Kalil J and Coelho V:
GATA3 and a dominant regulatory gene expression profile
discriminate operational tolerance in human transplantation. Clin
Immunol. 142:117–126. 2012.PubMed/NCBI View Article : Google Scholar
|
36
|
Schnopp C, Rad R, Weidinger A, Weidinger
S, Ring J, Eberlein B, Ollert M and Mempel M: Fox-P3-positive
regulatory T cells are present in the skin of generalized atopic
eczema patients and are not particularly affected by medium-dose
UVA1 therapy. Photodermatol Photoimmunol Photomed. 23:81–85.
2007.PubMed/NCBI View Article : Google Scholar
|
37
|
Wang L, Qian J, Lu Y, Li H, Bao H, He D,
Liu Z, Zheng Y, He J, Li Y, et al: Immune evasion of mantle cell
lymphoma: Expression of B7-H1 leads to inhibited T-cell response to
and killing of tumor cells. Haematologica. 98:1458–1466.
2013.PubMed/NCBI View Article : Google Scholar
|
38
|
Bao H, Lu P, Li Y, Wang L, Li H, He D,
Yang Y, Zhao Y, Yang L, Wang M, et al: Triggering of toll-like
receptor-4 in human multiple myeloma cells promotes proliferation
and alters cell responses to immune and chemotherapy drug attack.
Cancer Biol Ther. 11:58–67. 2011.PubMed/NCBI View Article : Google Scholar
|
39
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
40
|
Scheller HV, Jensen JK, Sørensen SO and
Harholt J: Biosynthesis of pectin. Physiologia Plantarum.
129:283–295. 2006.
|
41
|
Mukaka MM: Statistics Corner: A guide to
appropriate use of Correlation coefficient in medical research.
Malawi Med J. 24:69–71. 2012.PubMed/NCBI
|
42
|
Amieva M and Peek RM Jr: Pathobiology of
Helicobacter pylori-induced gastric cancer.
Gastroenterology. 150:64–78. 2016.PubMed/NCBI View Article : Google Scholar
|
43
|
Gonzalez-Valencia G, Atherton JC, Munoz O,
Dehesa M, la Garza AM and Torres J: Helicobacter pylori vacA
and cagA genotypes in mexican adults and childre. J Infect Dis.
182:1450–1454. 2000.PubMed/NCBI View
Article : Google Scholar
|
44
|
Liu C, Zhang Z and Zhu M: Immune responses
mediated by Th17 cells in Helicobacter pylori infection.
Integrative Med Int. 3:57–63. 2016.
|
45
|
Yu S, Kim HY, Chang YJ, DeKruyff RH and
Umetsu DT: Innate lymphoid cells and asthma. J Allergy Clin
Immunol. 133:943–950. 2014.PubMed/NCBI View Article : Google Scholar
|
46
|
Brooks C, Pearce N and Douwes J: The
hygiene hypothesis in allergy and asthma: An update. Curr Opin
Allergy Clin Immunol. 13:70–77. 2013.PubMed/NCBI View Article : Google Scholar
|
47
|
Kayhan B, Arasli M, Eren H, Aydemir S,
Kayhan B, Aktas E and Tekin I: Analysis of peripheral blood
lymphocyte phenotypes and Th1/Th2 cytokines profile in the systemic
immune responses of Helicobacter pylori infected
individuals. Microbiol Immunol. 52:531–538. 2008.PubMed/NCBI View Article : Google Scholar
|
48
|
Guiney DG, Hasegawa P and Cole SP:
Helicobacter pylori preferentially induces interleukin 12
(IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect
Immun. 71:4163–4166. 2003.PubMed/NCBI View Article : Google Scholar
|
49
|
Hafsi N, Voland P, Schwendy S, Rad R,
Reindl W, Gerhard M and Prinz C: Human dendritic cells respond to
Helicobacter pylori, promoting NK cell and Th1-effector
responses in vitro. J Immunol. 173:1249–1257. 2004.PubMed/NCBI View Article : Google Scholar
|
50
|
Amedei A, Cappon A, Codolo G, Cabrelle A,
Polenghi A, Benagiano M, Tasca E, Azzurri A, D'Elios MM, Del Prete
G and de Bernard M: The neutrophil-activating protein of
Helicobacter pylori promotes Th1 immune responses. J Clin
Invest. 116:1092–1101. 2006.PubMed/NCBI View Article : Google Scholar
|
51
|
Bagheri N, Razavi A, Pourgheysari B,
Azadegan-Dehkordi F, Rahimian G, Pirayesh A, Shafigh M,
Rafieian-Kopaei M, Fereidani R, Tahmasbi K and Shirzad H:
Up-regulated Th17 cell function is associated with increased peptic
ulcer disease in Helicobacter pylori-infection. Infect Genet
Evol. 60:117–125. 2018.PubMed/NCBI View Article : Google Scholar
|
52
|
Bagheri N, Shirzad H, Elahi S,
Azadegan-Dehkordi F, Rahimian G, Shafigh M, Rashidii R, Sarafnejad
A, Rafieian-Kopaei M, Faridani R, et al: Downregulated regulatory T
cell function is associated with increased peptic ulcer in
Helicobacter pylori-infection. Microb Pathog. 110:165–175.
2017.PubMed/NCBI View Article : Google Scholar
|
53
|
Bagheri N, Shirzad H, Mirzaei Y,
Nahid-Samiei M, Sanaei M, Rahimian G, Shafigh M, Zandi F, Tahmasbi
K and Razavi A: T-bet cells polarization in patients infected with
Helicobacter pylori increase the risk of peptic ulcer
development. Arch Med Res. 50:113–121. 2019.PubMed/NCBI View Article : Google Scholar
|
54
|
D'Elios MM and Czinn SJ: Immunity,
inflammation, and vaccines for Helicobacter pylori.
Helicobacter. 19 (Suppl 1):19–26. 2014.PubMed/NCBI View Article : Google Scholar
|
55
|
Downs-Canner S, Berkey S, Delgoffe GM,
Edwards RP, Curiel T, Odunsi K, Bartlett DL and Obermajer N:
Suppressive IL-17A(+)Foxp3(+) and ex-Th17 IL-17A(neg)Foxp3(+) Treg
cells are a source of tumour-associated Treg cells. Nat Commun.
8(14649)2017.PubMed/NCBI View Article : Google Scholar
|
56
|
Dianzani C, Minelli R, Gigliotti CL,
Occhipinti S, Giovarelli M, Conti L, Boggio E, Shivakumar Y,
Baldanzi G, Malacarne V, et al: B7h triggering inhibits the
migration of tumor cell lines. J Immunol. 192:4921–4931.
2014.PubMed/NCBI View Article : Google Scholar
|
57
|
Tan S, Noto JM, Romero-Gallo J, Peek RM Jr
and Amieva MR: Helicobacter pylori perturbs iron trafficking
in the epithelium to grow on the cell surface. PLoS Pathog.
7(e1002050)2011.PubMed/NCBI View Article : Google Scholar
|
58
|
Yang XO, Nurieva R, Martinez GJ, Kang HS,
Chung Y, Pappu BP, Shah B, Chang SH, Schluns KS, Watowich SS, et
al: Molecular antagonism and plasticity of regulatory and
inflammatory T cell programs. Immunity. 29:44–56. 2008.PubMed/NCBI View Article : Google Scholar
|
59
|
Zhuang Y, Shi Y, Liu XF, Zhang JY, Liu T,
Fan X, Luo J, Wu C, Yu S, Chen L, et al: Helicobacter
pylori-infected macrophages induce Th17 cell differentiation.
Immunobiology. 216:200–207. 2011.PubMed/NCBI View Article : Google Scholar
|
60
|
Das S, Suarez G, Beswick EJ, Sierra JC,
Graham DY and Reyes VE: Expression of B7-H1 on gastric epithelial
cells: Its potential role in regulating T cells during
Helicobacter pylori infection. J Immunol. 176:3000–3009.
2006.PubMed/NCBI View Article : Google Scholar
|
61
|
Mitchell P, Germain C, Fiori PL, Khamri W,
Foster GR, Ghosh S, Lechler RI, Bamford KB and Lombardi G: Chronic
exposure to Helicobacter pylori impairs dendritic cell
function and inhibits Th1 development. Infect Immun. 75:810–819.
2007.PubMed/NCBI View Article : Google Scholar
|